Evidence map›Paper›PMID 26539194›Full record

ArticleFrontiers in immunology2015

Integrins are Mechanosensors That Modulate Human Eosinophil Activation.

Mustafa Ahmadzai, Mike Small, Roma Sehmi, Gail Gauvreau, Luke J Janssen

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. αJournal of personalized medicine · 2021
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. DS-70, a novel and potent αBritish journal of pharmacology · 2018
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mustafa AhmadzaiFirestone Institute for Respiratory Health, St. Joseph's Hospital , Hamilton, ON , Canada ; Department of Biomedical Sciences, McMaster University , Hamilton, ON , Canada.
Mike SmallFirestone Institute for Respiratory Health, St. Joseph's Hospital , Hamilton, ON , Canada ; Department of Medicine, McMaster University , Hamilton, ON , Canada.
Roma SehmiFirestone Institute for Respiratory Health, St. Joseph's Hospital , Hamilton, ON , Canada ; Department of Medicine, McMaster University , Hamilton, ON , Canada.
Gail GauvreauFirestone Institute for Respiratory Health, St. Joseph's Hospital , Hamilton, ON , Canada ; Department of Medicine, McMaster University , Hamilton, ON , Canada.
Luke J JanssenFirestone Institute for Respiratory Health, St. Joseph's Hospital , Hamilton, ON , Canada ; Department of Medicine, McMaster University , Hamilton, ON , Canada.
St. Joseph's Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eosinophil migration to the lung is primarily regulated by the eosinophil-selective family of eotaxin chemokines, which mobilize intracellular calcium (Ca(2+)) and orchestrate myriad changes in cell structure and function. Eosinophil function is also known to be flow-dependent, although the molecular cognate of this mechanical response has yet to be adequately characterized. Using confocal fluorescence microscopy, we determined the effects of fluid shear stress on intracellular calcium concentration ([Ca(2+)]i) in human peripheral blood eosinophils by perfusing cells in a parallel-plate flow chamber. Our results indicate that fluid perfusion evokes a calcium response that leads to cell flattening, increase in cell area, shape change, and non-directional migration. None of these changes are seen in the absence of a flow stimulus, and all are blocked by chelation of intracellular Ca(2+) using BAPTA. These changes are enhanced by stimulating the cells with eotaxin-1. The perfusion-induced calcium response (PICR) could be blocked by pre-treating cells with selective (CDP-323) and non-selective (RGD tripeptides) integrin receptor antagonists, suggesting that α4β7/α4β1 integrins mediate this response. Overall, our study provides the first pharmacological description of a molecular mechanosensor that may collaborate with the eotaxin-1 signaling program in order to control human eosinophil activation.

Indexed as

calciumcytoskeletoneosinophilseotaxinmigration

Identifiers

PMID26539194
PMCPMC4611147
OpenAlexW2123175683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.